Generics

Filter

Current filters:

None

Popular Filters

1201 to 1208 of 1208 results

Mylan enters settlement and license deal with Roche over Xeloda

21-09-2011

US generic drugs giant Mylan (Nasdaq: MYL) says that it has entered into a settlement and license agreement…

GenericsLegalLicensingMylan LaboratoriesNorth AmericaOncologyRocheXeloda

Mylan’s Matrix gets tentative FDA approval for novel "co-packaged" version of HIV/AIDS drug

21-09-2011

US generic drugmaker Mylan (Nasdaq: MYL) says that its Indian subsidiary Matrix Laboratories has received…

Anti-viralsGenericsMatrixMylan LaboratoriesNorth AmericaRegulation

Hikma unit to increase focus on contract manufacturing, aimed at alleviating US drug shortages

20-09-2011

Jordan-headquartered Hikma Pharmaceuticals (LSE: HIK) says that its US subsidiary, West-Ward, is to focus…

GenericsHikma PharmaceuticalsMarkets & MarketingNorth AmericaWest-Ward

Malaysia Health Minister says new generics must not be delayed by interpretation of legislation

20-09-2011

Malaysia does not want the introduction of new generic drugs to be obstructed and delayed by conflicting…

Asia-PacificGenericsLegalRegulation

Glycotope enrolls first patient for “biobetter” of Roche cancer drug Herceptin

20-09-2011

Berlin, Germany-based glycomics specialist Glycotope GmbH says it has enrolled the first patients in…

BiotechnologyGenericsGlycotopeHerceptinOncologyResearchRochetrastuzumab

Experts stress the need to improve access to health care in India

19-09-2011

Providing adequate access to medicines and health care is one of the most challenging issues being faced…

Asia-PacificGenericsHealthcarePharmaceuticalPricing

1201 to 1208 of 1208 results

Back to top